ADiTx Therapeutics EV - Enterprise Value 2011-2026 | ADTX

Annual EV - Enterprise Value ADiTx Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
9.4 M	23 M	28.4 M	2.8 M	-1.25 M	17.3 M	2.97 M	1.65 M	84.9 K	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
28.4 M	-1.25 M	9.38 M

EV - Enterprise Value of other stocks in the Biotechnology industry

Issuer	EV - Enterprise Value	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	1.82 B	-	2.43 %	$ 254 M	Germany
Aligos Therapeutics ALGS	82.6 M	$ 8.59	-1.49 %	$ 84.9 M	USA
Allakos ALLK	122 M	-	-	$ 28.6 M	USA
Alterity Therapeutics Limited ATHE	-28.9 M	$ 3.73	1.78 %	$ 8.97 B	Australia
Aptinyx APTX	-18.3 M	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	58.2 M	-	-13.39 %	$ 1.45 M	USA
I-Mab IMAB	8.28 B	-	-	$ 866 M	China
AlloVir ALVR	-55.1 M	-	4.14 %	$ 49.1 M	USA
BioNTech SE BNTX	-4.91 B	$ 98.84	2.21 %	$ 27.2 B	Germany
Applied Molecular Transport AMTI	7.6 M	-	-	$ 10.1 M	USA
Alexion Pharmaceuticals, Inc. ALXN	1.95 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	168 B	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	525 M	-	-13.47 %	$ 169 M	France
Burford Capital Limited BUR	3.22 B	$ 4.71	4.56 %	$ 760 M	Britain
Brainstorm Cell Therapeutics BCLI	11 M	-	-2.5 %	$ 5.88 M	USA
Cabaletta Bio CABA	253 M	$ 3.27	2.03 %	$ 329 M	USA
Applied Therapeutics APLT	563 M	-	-	$ 8.42 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	3.41 B	-	-1.52 %	$ 24.7 M	USA
BeiGene, Ltd. BGNE	-720 M	-	0.49 %	$ 251 B	Cayman-islands
bluebird bio BLUE	270 M	-	-	$ 546 M	USA
Midatech Pharma plc MTP	-1.76 M	-	-18.52 %	$ 27.3 M	Britain
Amphastar Pharmaceuticals AMPH	1.92 B	$ 21.6	1.12 %	$ 1.01 B	USA
Checkpoint Therapeutics CKPT	174 M	-	-	$ 169 M	USA
Институт стволовых клеток человека ISKJ	14.1 M	-	-	-	Russia
Adverum Biotechnologies ADVM	125 M	-	-	$ 86.2 M	USA
Advaxis ADXS	-3.02 M	-	-9.65 %	$ 45.9 M	USA
Clearside Biomedical CLSD	122 M	-	-	$ 25.3 M	USA
Aeterna Zentaris AEZS	10.3 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	3.93 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	-23.2 M	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	493 M	$ 1.54	4.76 %	$ 396 M	USA
Applied Genetic Technologies Corporation AGTC	-9.16 M	-	-	$ 26.5 M	USA
Can-Fite BioPharma Ltd. CANF	647 M	$ 3.04	4.11 %	$ 5 M	Israel
Aquestive Therapeutics AQST	540 M	$ 4.16	-0.72 %	$ 445 M	USA
Arcutis Biotherapeutics ARQT	3.64 B	$ 25.23	4.6 %	$ 3.21 B	USA
Chimerix CMRX	95.8 M	-	-	$ 756 M	USA
Concert Pharmaceuticals CNCE	14.7 M	-	-	$ 401 M	USA
AIkido Pharma AIKI	9.53 M	-	1.93 %	$ 17.4 M	USA
Celldex Therapeutics CLDX	2.07 B	$ 33.31	2.19 %	$ 2.21 B	USA
Autolus Therapeutics plc AUTL	629 M	$ 1.5	2.04 %	$ 399 M	Britain
Aptose Biosciences APTO	36.2 M	-	-45.71 %	$ 1.2 M	Canada
Cidara Therapeutics CDTX	9.99 M	-	-	$ 1.41 B	USA
AVROBIO AVRO	-35.4 M	-	1083.1 %	$ 745 M	USA
CNS Pharmaceuticals CNSP	-2.04 M	$ 2.59	3.19 %	$ 1.15 M	USA
Ayala Pharmaceuticals AYLA	5.32 M	-	-	$ 7.46 M	Israel
AstraZeneca PLC AZN	59.6 B	-	-	$ 96.9 B	Britain
Akero Therapeutics AKRO	2.99 B	-	-	$ 3.67 B	USA
CTI BioPharma Corp. CTIC	664 M	-	-	$ 1.2 B	USA
CureVac N.V. CVAC	3.19 B	-	-	$ 867 M	Germany
Akari Therapeutics, Plc AKTX	79.3 B	$ 4.55	7.12 %	$ 306 B	Britain